Arialys Therapeutics

News

April 25, 2023

Arialys Presents at AAN Annual Meeting 2023

On April 24, Mickey Matsumoto, Ph.D., CSO of Arialys, gave an oral presentation entitled, "Monoclonal Humanized One-Armed Antibody Blocking Therapy for Anti-NMDAR Encephalitis."

Click here to view the abstract.

Sign up for news updates

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

News

Sign up for news updates

Follow us